Apply on Employer Site

Novo Nordisk · 16 hours ago

HEOR Evidence Strategy Director

Plainsboro, NJ

Full-time

Onsite

Director/Executive

$225K/yr - $280K/yr

8+ years exp

Novo Nordisk is a global healthcare company focused on improving the quality of life for patients. The HEOR Evidence Strategy Director will lead the development of health economics and outcomes research strategies, ensuring robust evidence generation and value communication for key products in the U.S. market.

BiotechnologyHealth CareMedicalPharmaceutical

Growth Opportunities

Responsibilities

Lead HEOR strategy for a key product: Independently develops HEOR and real world strategy, leads evidence generation and value communications for the product This includes interactions with commercial and medical functions to support development of portfolio strategies, development of HEOR/Real world evidence plans, prioritization of plans, generation of evidence and delivery of value communication tools

Adequately resource prioritized evidence plans: As an independent HEOR leader within the business unit, it is expected that the director will have to consider creative and innovative outsourcing strategies to adequately resource the projects and priorities Lead HEOR input into policy issues and economic evaluations for NNI products within the portfolio: Works independently with medical, public policy, commercial colleagues to input into external policy initiatives and programs

Provide HEOR input into drug development and clinical trial programs: Works directly with global colleagues to input HEOR and RWE strategies into the global product development plans through the PDP forum Develop real world evidence plan: Leads the development of real world evidence plans for projects based on needs of the product portfolio

Serve as an internal research method expert: Acts as a key subject matter expert in various methodological and analytic functions and provides consultation to / collaborates with key internal and external stakeholders directly to provide tangible solutions that are aligned to portfolio strategy

Ensure scientific rigor and credibility: Serves as a key member of the HEOR Research Review Committee (RRC) to provide expertise in research methods, protocol development and statistical analysis for all key HEOR studies. Provides functional support in HEOR publication planning by review of abstracts, manuscripts, and other key HEOR publications prior to submission

Qualification

HEOR strategy developmentReal world evidence generationHealth economics expertiseExperience in liver diseaseU.S. healthcare systemsPeer-reviewed publicationsCommunication skillsNegotiation skills

Required

A Doctorate (preferred) or Masters degree, preferably in health economics, epidemiology, outcomes research, public health, business/health services research, biostatistics

At least 8 years of experience in health economics, outcomes research, pricing, reimbursement, and/or portfolio analysis

Advanced knowledge and experience in conducting health economics, health related quality of life, and/or health services research studies and the evaluation of health care interventions

Comprehensive knowledge of health care systems in the U.S., including managed care organizations, integrated health systems, PBMs, Medicare, and Medicaid

Demonstrated track record of peer-reviewed scientific publications, dossier development, and strategic, customer-focused HEOR tool development

Experience in preparing or reviewing materials for drug formularies

Proven record of outstanding written and verbal communication and negotiation skills, with experience interacting with and presenting to key customers